| 1 |
33909826 | Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes. | 2021 |
1 |
| 2 |
34073233 | KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer. | 2021 May 26 |
2 |
| 3 |
30573691 | Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas. | 2019 Apr 15 |
2 |